Accumulating evidence demonstrated that lower OS rate, poorer TNM stage, larger tumor size and metastasis in patients with hilarcholangiocarcinoma (HCCA) are correlated with the high expression levels of MALAT1. Here, MALAT1 is linked to neoplasm.